Augmentation of human NK activity and maturation of monocyte-derived dendritic cells in vitro elicited by Agaricus blazei Murill

Biotherapy

Volumn 15, Issue 4, 2001, Pages 503-507

  Nakane, K ^a   Matsuura, Y ^a   Kubo, S ^a   Takeda, T ^a   Itoh, T ^a   Okugawa, K ^a   Yano, Y ^a   Ueda, Y ^a  

^a Takeda Clinic of Immunity and Gene   (Japan)

Author keywords

Agaricus blazei Murill; Dendritic cell; NK activity

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; EUROPIUM; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

AGARICUS BLAZEI; ARTICLE; CANCER IMMUNOTHERAPY; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; MONOCYTE; NATURAL KILLER CELL;

EID: 0034858736     PISSN: 09142223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei "Himematsutake" and its mechanisms in tumor-bearing mice
2. Inhibitory action of a (1, 6)-β-D-glucan-protein complex isolated from Agaricus blazei Murill ("Himematsutake") on Meth A fibrosarcoma bearing mice and its antitumor mechanism
3. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin-4 and down regulated by tumor necrosis factor-α
4. Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei Murill